Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
APIs
Reply
10 Jan 2025
Reply
13 Nov 2021
Reply
18 Oct 2021
Reply
22 Sep 2018
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FDF DOSSIERS
Reply
31 Aug 2023
Reply
02 Jun 2021
Reply
08 Jan 2021
Reply
22 Nov 2018
Reply
13 Sep 2018
Reply
02 Aug 2018
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
29
PharmaCompass offers a list of Sulodexide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sulodexide manufacturer or Sulodexide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sulodexide manufacturer or Sulodexide supplier.
PharmaCompass also assists you with knowing the Sulodexide API Price utilized in the formulation of products. Sulodexide API Price is not always fixed or binding as the Sulodexide Price is obtained through a variety of data sources. The Sulodexide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Aterina manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aterina, including repackagers and relabelers. The FDA regulates Aterina manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aterina API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Aterina manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Aterina supplier is an individual or a company that provides Aterina active pharmaceutical ingredient (API) or Aterina finished formulations upon request. The Aterina suppliers may include Aterina API manufacturers, exporters, distributors and traders.
click here to find a list of Aterina suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Aterina DMF (Drug Master File) is a document detailing the whole manufacturing process of Aterina active pharmaceutical ingredient (API) in detail. Different forms of Aterina DMFs exist exist since differing nations have different regulations, such as Aterina USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Aterina DMF submitted to regulatory agencies in the US is known as a USDMF. Aterina USDMF includes data on Aterina's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aterina USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Aterina suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Aterina Drug Master File in Korea (Aterina KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Aterina. The MFDS reviews the Aterina KDMF as part of the drug registration process and uses the information provided in the Aterina KDMF to evaluate the safety and efficacy of the drug.
After submitting a Aterina KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Aterina API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Aterina suppliers with KDMF on PharmaCompass.
Aterina Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aterina GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aterina GMP manufacturer or Aterina GMP API supplier for your needs.
A Aterina CoA (Certificate of Analysis) is a formal document that attests to Aterina's compliance with Aterina specifications and serves as a tool for batch-level quality control.
Aterina CoA mostly includes findings from lab analyses of a specific batch. For each Aterina CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aterina may be tested according to a variety of international standards, such as European Pharmacopoeia (Aterina EP), Aterina JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aterina USP).
Comment (4)
